Graticule Asia Macro Advisors LLC Atai Life Sciences N.V. Transaction History
Graticule Asia Macro Advisors LLC
- $0
- Q4 2023
Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
96Shares Held
13.1MCall Options Held
229KPut Options Held
114K-
Morgan Stanley New York, NY2.67MShares$3.47 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.22MShares$2.88 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.4MShares$1.82 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0794KShares$1.03 Million0.0% of portfolio
-
Brown University719KShares$934,0500.61% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $216M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...